Cite Filings / CBIO / 0000834237-21-003995
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

CRESCENT BIOPHARMA, INC. · Filed 2021-01-29 · Acc 0000834237-21-003995

Documents 1

  • SC 13G/A Amended Statement of Ownership , us38000q1022_012921.txt

Around this filing

  • 2021-02-11 SC 13G/A Amended Statement of Ownership
  • 2021-01-29 SC 13G/A Amended Statement of Ownership
  • 2021-01-22 4 SVP Finance, CFO acquired 34,500 shares (grant or award)
  • 2021-01-22 4 SVP Clinical Development, CMO acquired 34,500 shares (grant or award)
  • 2021-01-22 4 SVP of Research, CSO acquired 34,500 shares (grant or award)
  • 2021-01-22 4 President, CEO acquired 96,250 shares (grant or award)
  • 2020-12-10 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Venrock Healthcare Capital Partners III, L.P. 5.9%
  2. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 4.34%
  3. 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 9.8%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 8.1%
Loading us38000q1022_012921.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…